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INTRODUCTION
Muscular dystrophies with an autosomal recessive mode
of inheritance comprise of a genetically heterogeneous group
of disorders. Among these, Miyoshi myopathy (MM) is an
early-adult onset, autosomal recessive form of distal muscu-
lar dystrophy, characterized by predominant involvement in
the calf muscles and highly elevated serum creatine kinase
(CK) levels (1). MM has been known to be caused by muta-
tions in the dysferlin gene (DYSF) on chromosome 2p13 (2).
Mutations in the same gene were also identified in patients
with limb-girdle muscular dystrophy type 2B (LGMD2B)
(3), and distal anterior compartment myopathy (4). These
diseases caused by mutations in DYSF are known by the term
‘dysferlinopathy’.
Although MM patients and their mutations in the DYSF
gene have been found from all over the world, only a few cases
have been reported in Korea (5-8). Considering that there
have been many reports of MM among Japanese population
(9), the incidence of MM might be underestimated in Korea
since both countries are geographically and ethnically related
with each other (10, 11). In the present study, we performed
clinical and genetic analysis of three Korean patients with
MM and found that all patients had compound heterozygous
mutations in the DYSF gene.
MATERIALS AND METHODS
Subjects
Three unrelated and non-consanguineous patients with
clinical features of MM were evaluated (Table 1). All the pa-
tients experienced early adulthood onset of slowly progres-
sive muscle weakness, which preferentially involved muscles
in the lower extremities. Patients 1 and 2 had a history of
steroid medication under the presumptive diagnosis of poly-
myositis according to the muscle biopsies and both showed
transient responses. Patient 3 suffered from diabetes and show-
ed the EMG findings of superimposed peripheral polyneuro-
pathy.
Mutation analysis
The genomic DNA was extracted from the peripheral blood
leukocytes using a Wizard Genomic DNA Purification kit
according to the manufacturer’s instructions (Promega, Madi-
son, WI, U.S.A.). All the coding exons as well as the flanking
introns of the DYSF gene were amplified using the primer
sets designed by the authors (primer sets available on request).
A polymerase chain reaction was performed with a thermal
cycler (model 9700, Applied Biosystems, Foster City, CA,
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Clinical and Genetic Analysis of Korean Patients with Miyoshi 
Myopathy: Identification of Three Novel Mutations in the DYSF Gene
Miyoshi myopathy (MM) is an autosomal recessive distal muscular dystrophy caused
by mutations in the dysferlin gene (DYSF) on chromosome 2p13. Although MM
patients and their mutations in the DYSF gene have been found from all over the
world, there is only one report of genetically confirmed case of MM in Korea. Recently,
we encountered three unrelated Korean patients with MM and two of them have
previously been considered as having a type of inflammatory myopathy. The clinical
and laboratory evaluation showed typical features of muscle involvement in MM in
all patients but one patient initially had moderate proximal muscle involvement and
another showed incomplete quadriparesis with rapid progression. Direct sequenc-
ing analysis of the DYSF gene revealed that each patient had compound heterozy-
gous mutations (Gln832X and Trp992Arg, Gln832X and Trp999Cys, and Lys1103X
and Ile1401HisfsX8, respectively) among which three were novel. Although MM has
been thought to be quite rare in Korea, it should be considered in a differential diag-
nosis of patients exhibiting distal myopathy.
Key Words : Distal Myopathies; Muscular Diseases; DYSF protein, human; Muscular Dystrophies, Limb-Gir-
dle; Mutation
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U.S.A.) using the following conditions: 32 cycles of denatu-
ration at 94℃ for 30 sec, annealing at 60℃ for 30 sec, and
extension at 72℃for 30 sec. After the amplicon (5  L) treat-
ment with 10 U shrimp alkaline phosphatase and 2 U exonu-
clease I (USB Corp., Cleveland, OH, U.S.A.), direct sequenc-
ing was performed with the BigDye Terminator Cycle Seq-
uencing Ready Reaction kit (Applied Biosystems) using a
ABI Prism 3,100 genetic analyzer (Applied Biosystems). All
the novel mutations were confirmed by sequencing 100 con-
trol chromosomes.
RESULTS
Clinical findings
Patient 1 was a 45 yr-old male patient who had presented
with progressive weakness in both lower extremities for the
previous 17 yr. He noticed difficulty in running and atrophy
of the lower leg muscles at 27 yr of age. The muscle weak-
ness and atrophy progressed. A neurological examination
showed bilateral motor weakness and symmetric atrophy of
the entire lower extremity muscles, which were more severe
on the distal part than on the proximal part. Marked atrophy
of the lower leg muscles with relatively spared pelvic girdle
and upper thigh muscles resulted in a stalk-leg appearance.
He required a cane for level walking and also complained of
decreased pinch strength. He had been diagnosed of having
a polymyositis at the age of 28 yr as a result of a muscle biopsy
of the medial gastrocnemius showing myopathic changes
with inflammatory cell infiltration. Immunohistochemical
stain was not performed on the biopsy specimen. His 43 yr-
old younger sister was affected in the same way in her early
thirties and found it difficult to walk up and downhills. Since
then, the muscle weakness worsened so that walking was still
possible but only for short distances using a cane. She also
Patient Sex/
age (yr)
Age at onset 
(yr)
Muscle biopsy finding EMG
CK level
(IU/L)
Family 
history
Distribution
1 M/44 28 Inflammatory myopathy myopathic 5,400 + Thigh, Lower leg, Fore-arm
2 F/30 26 Inflammatory myopathy myopathic 5,152 - Upper arm, Thigh, Lower leg
3 M/37 18 Not available myopathic 2,100 + Upper arm, Fore-arm, 
Thigh, Lower leg
Table 1. Summary of the clinical and laboratory findings of the patients
Fig. 1. Novel DYSF gene mutations identified in the present study
(arrows). (A) A nonsense mutation (c.2494C>T; Gln832X) observed
in patients 1 and 2; (B) a missense mutation (c.2974T>C; Trp992-
Arg) observed in patient 2; and (C) a nonsense mutation (c.3307A>
T; Lys1103X) observed in patient 3.
A
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Control
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had difficulty in holding her baby due to extended weakness
of her upper extremity muscles. Standing on their tip-toe or
heels were impossible in both patients. They could stand from
sitting position only with the aid of their hands.
Patient 2 was a 30 yr-old female who presented with dif-
ficulty in stair walking and pain in her low back and knee.
Difficulty in climbing stairs developed at 26 yr of age and
this difficulty in walking gradually worsened so that she could
not climb stairs without the support of her upper extremities.
A neurological examination showed atrophy of both calf mus-
cles, decreased strength of the lower extremity muscles, and
an absent tendon reflex. The Gowers’ sign was positive. She
could not stand on her tip-toe, but standing on her heels was
possible. The EMG revealed the myopathic changes in gas-
trocnemius, rectus femoris, and biceps brachii muscles. A mus-
cle biopsy without immunohistochemial stain from the biceps
brachii suggested a diagnosis of inflammatory myopathy. Mag-
netic resonance imaging of her lower leg disclosed symmet-
ric fatty degeneration and decreased muscle volume of the
posterior compartment muscles in both lower legs. The ante-
rior and lateral compartment muscles had either a normal or
a relatively normal signal intensity and morphology. The pa-
tient denied a family history of neuromuscular disease.
Patient 3 was a 37-yr-old man with quadriparesis who first
became aware of periodic weakness in his lower extremities at
the age of 18 yr. He noticed difficulties in standing and climb-
ing stairs at the age of 21 and could not walk by himself by
the age of 33. An examination at the age of 37 showed incom-
plete quadriparesis and he could walk with a four-point crutch.
His older sister developed lower extremity weakness and atro-
phy at the age of 18 yr and could not walk by the age of 36.
Mutation analysis
Direct sequencing analysis identified five heterozygous
mutations in the DYSF gene including three novel muta-
tions (Fig. 1). Patient 1 and his sister had compound hetero-
zygous mutations of a novel C to T transition (c.2494C>T)
in exon 24 resulting in a nonsense mutation (Gln832X) along
with a previously reported missense mutation (c.2997G>T;
Trp999Cys). The Gln832X mutation was also found in the
patient 2 with a novel missense mutation (c.2974C>T; Trp-
992Arg). Patient 3 had two mutations including a novel A
to T transversion (c.3307A>T) in exon 30, which resulted
in a nonsense mutation (Lys1103X), and a previously reported
insertion mutation (c.4200dupC) in exon 39 resulting in a
frame shift mutation (Ile1401HisfsX8). Three novel muta-
tions (Gln832X, Trp992Arg, and Lys1103X) were not detect-
ed in 100 control chromosomes.
DISCUSSION
This study identified five different mutations in three Kore-
an MM patients, and all patients had compound heterozygous
mutation in the DYSF gene. The c.2997G>T (Trp999Cys)
mutation is reported to be one of the most frequent muta-
tions found in Japanese MM patients, and has been associat-
ed with a significantly later onset and a relatively mild form
of MM (9). The age at onset in patient 2 with the c.2997G>T
mutation was delayed compared with the other patients, but
was earlier than the mean age at onset reported elsewhere (9).
The c.4200dupC mutation (Ile1401HisfsX8), which was
found in two patients with MM or LGMD2B, appeared in
the Dysferlin sequence variations in the Leiden Muscular Dys-
trophy pages. The c.2494C>T (Gln832X) mutation was novel
and was found in 2 unrelated patients, which might be due
to a possible founder effect in the Korean population. How-
ever, it will be necessary to perform haplotype analysis and
collect more data on MM patients in Korea to address this
issue.
Some patients with MM can be easily misdiagnosed as hav-
ing an inflammatory myopathy because inflammation is fre-
quently observed in patients with MM and the inflammatory
changes found in patients with MM are indistinguishable from
those observed in patients with inflammatory myopathy (12).
Indeed, two patients in this study had previously been sus-
pected of having a form of inflammatory myopathy based
on the muscle biopsy findings. McNally et al. (13) reported
that the presence of inflammation is not an exclusion crite-
rion in muscular dystrophy related to a dysferlin deficiency,
while the muscle biopsies of MM or LGMD2B patients gen-
erally demonstrates signs of a dystrophy with a dysferlin defi-
ciency.
It is possible that some MM patients have been erroneously
diagnosed with polymyositis based on the absence of dystro-
phic features and the presence of inflammation in the mus-
cle biopsies. Consequently, MM might has been considered
to be quite rare in Korea. Therefore, MM should be consid-
ered when making a differential diagnosis of patients exhibit-
ing distal myopathy and muscular inflammation on muscle
biopsies, and DYSF gene analysis should also be considered.
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